EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.63 | medicine | the efficiacy of 6-O-benzylguanine as a chemomodulator depends on the extent of depletion of 6-O-methylguanine DNA methyltransferase in normal tissues and the optimal therapeutic index for combination of 6-O-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea therapy should be achieved by depleting 6-O-methylguanine DNA methyltransferase in the target tumor for 24 h with minimal depletion in normal tissues | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.63 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.63 | bone marrow | - |
Homo sapiens | - |
2.1.1.63 | brain | - |
Homo sapiens | - |
2.1.1.63 | kidney | - |
Homo sapiens | - |
2.1.1.63 | liver | - |
Homo sapiens | - |
2.1.1.63 | lung | - |
Homo sapiens | - |
2.1.1.63 | spleen | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.1.1.63 | additional information | - |
developmemt of a novel fluorometric oligonucleotide assay to measure enzyme activity in cellular and tissue extracts | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.63 | DNA containing 6-O-methylguanine + [protein]-L-cysteine | - |
Homo sapiens | DNA lacking 6-O-methylguanine + [protein]-S-methyl-L-cysteine | - |
? |